Back
ProShares UltraShort Nasdaq Biotech Vs. ProShares UltraShort MSCI Brazil Capped Industry Stock Comparison
Sell
43
BIS
ProShares UltraShort Nasdaq Biotech
Last Price:
20.74
Seasonality Move:
-13.99%
Buy
58
BZQ
ProShares UltraShort MSCI Brazil Capped
Last Price:
12.07
Seasonality Move:
-1.46%
Sell
43
ProShares UltraShort Nasdaq Biotech (BIS)
is a Sell
Is ProShares UltraShort Nasdaq Biotech a Buy, Sell or Hold?
- The current ProShares UltraShort Nasdaq Biotech [BIS] share price is $20.24. The Score for BIS is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
- BIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
58
ProShares UltraShort MSCI Brazil Capped (BZQ)
is a Buy
Is ProShares UltraShort MSCI Brazil Capped a Buy, Sell or Hold?
- The current ProShares UltraShort MSCI Brazil Capped [BZQ] share price is $12.07. The Score for BZQ is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
- BZQ is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
BIS Stock Price Chart
What is ProShares UltraShort Nasdaq Biotech's stock price today?
-
The ProShares UltraShort Nasdaq Biotech share price today is $20.24
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIS is experiencing selling pressure, which indicates risk of future bearish movement.
BZQ Stock Price Chart
What is ProShares UltraShort MSCI Brazil Capped's stock price today?
-
The ProShares UltraShort MSCI Brazil Capped share price today is $12.07
The current trend is moderately bearish and BZQ is experiencing selling pressure, which indicates risk of future bearish movement.
BIS Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.62 | Buy |
| Relative Strength Index (14 RSI): | 59.49 | Buy |
| Chaikin Money Flow: | -2089 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (18.11 - 20.33) | Buy |
| Bollinger Bands (100): | (17.13 - 19.91) | Buy |
BZQ Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.25 | Buy |
| Relative Strength Index (14 RSI): | 48.61 | Sell |
| Chaikin Money Flow: | -22170 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.53 - 12.71) | Sell |
| Bollinger Bands (100): | (10.64 - 12.04) | Buy |
BIS Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.47 | Sell |
| 20-day SMA: | 19.58 | Buy |
| 50-day SMA: | 18.4 | Buy |
| 200-day SMA: | 20.42 | Sell |
| 8-day EMA: | 20.24 | Sell |
| 20-day EMA: | 19.68 | Buy |
| 50-day EMA: | 18.98 | Buy |
| 200-day EMA: | 19.81 | Buy |
BZQ Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 12.66 | Sell |
| 20-day SMA: | 12.25 | Sell |
| 50-day SMA: | 11.69 | Buy |
| 200-day SMA: | 12.48 | Sell |
| 8-day EMA: | 12.47 | Sell |
| 20-day EMA: | 12.29 | Sell |
| 50-day EMA: | 11.9 | Buy |
| 200-day EMA: | 12.97 | Sell |
ProShares UltraShort Nasdaq Biotech Earnings Growth & BIS Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort MSCI Brazil Capped Earnings Growth & BZQ Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
ProShares UltraShort Nasdaq Biotech Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
ProShares UltraShort MSCI Brazil Capped Technical Analysis
| Apr 15 | Apr 16 | Apr 17 | Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | 26 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||